You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low Risk Myelodysplastic Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

MDS Trial in Houston (Sertraline, Bone Marrow Aspirate/Biopsy)

Terminated
  • Myelodysplastic Syndromes
  • Houston, Texas
  • +1 more
May 31, 2022

Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Non-transfusion-dependent Thalassemia
  • +2 more
  • Düsseldorf, Germany
  • +19 more
Mar 18, 2022

MDS Trial (Yisui granule, Placebo)

Not yet recruiting
  • MDS
  • Yisui granule
  • Placebo
  • (no location specified)
Jan 13, 2023

MDS, Transfusion-dependent Anemia Trial in France (Transfusion)

Recruiting
  • Myelodysplastic Syndromes
  • Transfusion-dependent Anemia
  • Transfusion
  • Abbeville, France
  • +18 more
Apr 4, 2022

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

Low Risk MDS Trial (R906289 Monosodium (R289 Na))

Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
Jul 22, 2022

Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome, Low-risk Myelodysplastic Syndrome Trial in France, Germany,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Nantes, Nantes Cedex 1, France
  • +7 more
Dec 20, 2021

MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Thrombocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2022

MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes (MDS)
  • Acute Myelogenous Leukemia (AML)
  • low dose 5'-azacitidine
  • Basking Ridge, New Jersey
  • +6 more
Dec 1, 2022

Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome
  • Strasbourg, Bajo Rin, France
  • +24 more
Nov 22, 2021

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
Jan 12, 2022

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

Recruiting
  • Aplastic Anemia
  • +3 more
  • Anti-Thymocyte Globulin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

Anemia, MDS Trial in Germany (Canakinumab Injection)

Recruiting
  • Anemia
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Berlin, Germany
  • +5 more
Nov 8, 2022

MDS Trial (Roxadustat in combination with retinoic acid)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Roxadustat in combination with retinoic acid
  • (no location specified)
Aug 26, 2023